Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Western Europe

The Western Europe Pharma & Healthcare Insight service provides analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting pharma and healthcare markets across Western Europe. The service includes access to the very latest analysis plus a searchable archive of articles and data.

To gain FREE trial access for a limited period, click trial.


Latest Stories

United Kingdom / Industry

GlaxoSmithKline (GSK)'s Q210 results reinforce BMI's view that emerging markets will drive industry growth. The company delivered a strong performance in H110, posting a 7.0% increase in net sales to US$22.02bn. However, on comparing GSK's financial performance between Q2 and Q1, it is evident that the company has suffered at the hands of cost-containment measures implemented by... 2010-07-22


Sweden / Industry

In 2009, the Swedish medical device market was valued at SEK18.51bn (US$2.16bn), following its 2004-2009 compound annual growth rate (CAGR) of 8.49% in local currency terms and 5.21%... 2010-07-21


Italy / Industry

Silvio Berlusconi's government has won a confidence vote in the Senate over its EUR25bn (US$32bn) austerity package aimed at lowering the country's budget deficit from 5.3% of GDP in... 2010-07-21


Industry Developments

United Kingdom

GlaxoSmithKline (GSK)'s Q210 results reinforce BMI's view that emerging markets will drive industry growth. The company delivered a strong performance in H110, posting a 7.0% increase... 2010-07-22


Sweden

In 2009, the Swedish medical device market was valued at SEK18.51bn (US$2.16bn), following its 2004-2009 compound annual growth rate (CAGR) of 8.49% in local currency terms and 5.21%... 2010-07-21


Italy

Silvio Berlusconi's government has won a confidence vote in the Senate over its EUR25bn (US$32bn) austerity package aimed at lowering the country's budget deficit from 5.3% of GDP in... 2010-07-21


BMI view: The proposed strengthening of the EU's safety monitoring for pharmaceuticals could lead to more rapid withdrawal of products that present an unacceptable level of risk. We... 2010-07-16

Western Europe InsightWestern Europe Channels Western Europe Countries